nan jing zi jin tou zi ji tuan you xian ze ren gong si - Net Worth and Insider Trading

nan jing zi jin tou zi ji tuan you xian ze ren gong si Net Worth

The estimated net worth of nan jing zi jin tou zi ji tuan you xian ze ren gong si is at least $253 Million dollars as of 2024-11-07. nan jing zi jin tou zi ji tuan you xian ze ren gong si is the of Qyuns Therapeutics Co Ltd and owns about 18,750,000 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) stock worth over $253 Million. Details can be seen in nan jing zi jin tou zi ji tuan you xian ze ren gong si's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that nan jing zi jin tou zi ji tuan you xian ze ren gong si has not made any transactions after 2024-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of nan jing zi jin tou zi ji tuan you xian ze ren gong si

nan jing zi jin tou zi ji tuan you xian ze ren gong si Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, nan jing zi jin tou zi ji tuan you xian ze ren gong si owns 1 companies in total, including Qyuns Therapeutics Co Ltd (HKSE:02509) .

Click here to see the complete history of nan jing zi jin tou zi ji tuan you xian ze ren gong si’s form 4 insider trades.

Insider Ownership Summary of nan jing zi jin tou zi ji tuan you xian ze ren gong si

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02509	Qyuns Therapeutics Co Ltd	2024-03-20

nan jing zi jin tou zi ji tuan you xian ze ren gong si Latest Holdings Summary

nan jing zi jin tou zi ji tuan you xian ze ren gong si currently owns a total of 1 stock. nan jing zi jin tou zi ji tuan you xian ze ren gong si owns 18,750,000 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) as of March 20, 2024, with a value of $253 Million.

Latest Holdings of nan jing zi jin tou zi ji tuan you xian ze ren gong si

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02509	Qyuns Therapeutics Co Ltd	2024-03-20	18,750,000	13.50	253,125,000

Holding Weightings of nan jing zi jin tou zi ji tuan you xian ze ren gong si

nan jing zi jin tou zi ji tuan you xian ze ren gong si Form 4 Trading Tracker

According to the SEC Form 4 filings, nan jing zi jin tou zi ji tuan you xian ze ren gong si has made a total of 1 transactions in Qyuns Therapeutics Co Ltd (HKSE:02509) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Qyuns Therapeutics Co Ltd is the sale of 0 shares on March 20, 2024, which brought nan jing zi jin tou zi ji tuan you xian ze ren gong si around $0.

Insider Trading History of nan jing zi jin tou zi ji tuan you xian ze ren gong si

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

nan jing zi jin tou zi ji tuan you xian ze ren gong si Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

nan jing zi jin tou zi ji tuan you xian ze ren gong si Ownership Network

Ownership Network List of nan jing zi jin tou zi ji tuan you xian ze ren gong si

No Data

Ownership Network Relation of nan jing zi jin tou zi ji tuan you xian ze ren gong si

nan jing zi jin tou zi ji tuan you xian ze ren gong si Owned Company Details

What does Qyuns Therapeutics Co Ltd do?

Who are the key executives at Qyuns Therapeutics Co Ltd?

nan jing zi jin tou zi ji tuan you xian ze ren gong si is the of Qyuns Therapeutics Co Ltd. Other key executives at Qyuns Therapeutics Co Ltd include Yu Guo'an , Taizhou Xinfu Tongxin Enterprise Management Partnership (Limited Partnership) , and 2201 Interest of corporation controlled by you tai zhou yi yao gao xin ji shu chan ye tou zi fa zhan you xian gong si .

Qyuns Therapeutics Co Ltd (HKSE:02509) Insider Trades Summary

Over the past 18 months, nan jing zi jin tou zi ji tuan you xian ze ren gong si made 1 insider transaction in Qyuns Therapeutics Co Ltd (HKSE:02509) with a net sale of 0. Other recent insider transactions involving Qyuns Therapeutics Co Ltd (HKSE:02509) include a net sale of 0 shares made by tai zhou hua cheng yi xue tou zi ji tuan you xian gong si , a net sale of 0 shares made by Matrix China VI GP GP, Ltd. , and a net sale of 0 shares made by Hangzhou Quanyi Investment Management Partnership (General Partnership) .

In summary, during the past 3 months, insiders sold 0 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Qyuns Therapeutics Co Ltd (HKSE:02509)'s detailed insider trading history can be found in Insider Trading Tracker table.

Qyuns Therapeutics Co Ltd Insider Transactions

No Available Data

nan jing zi jin tou zi ji tuan you xian ze ren gong si Mailing Address

Above is the net worth, insider trading, and ownership report for nan jing zi jin tou zi ji tuan you xian ze ren gong si. Currently GuruFocus does not have mailing address information for nan jing zi jin tou zi ji tuan you xian ze ren gong si.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.